TECON BIOLOGY Co.LTD (SHE:002100)
China · Delayed Price · Currency is CNY 7.99
-0.04 (-0.50%)
Sep 14, 2026, 3:04 PM CST
TECON BIOLOGY Co.LTD Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 10,963 | 10,062 | 8,942 | 11,973 | 11,255 | 11,517 | |
Market Cap Growth | 17.40% | 12.52% | -25.31% | 6.39% | -2.28% | 1.15% |
Enterprise Value | 16,782 | 13,435 | 12,563 | 15,378 | 14,181 | 15,091 |
Last Close Price | 8.03 | 7.28 | 6.25 | 8.37 | 7.71 | 9.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 47.77 | 14.78 | - | 40.08 | - |
Forward PE | 34.87 | 14.99 | 10.10 | 27.14 | 9.79 | 27.03 |
PS Ratio | 0.67 | 0.59 | 0.52 | 0.63 | 0.66 | 0.73 |
PB Ratio | 1.29 | 1.18 | 1.05 | 1.51 | 1.17 | 1.49 |
P/TBV Ratio | 2.08 | 1.57 | 1.38 | 2.04 | 1.48 | 1.69 |
P/FCF Ratio | - | 5264.28 | 16.70 | 15.95 | - | - |
P/OCF Ratio | 42.53 | 26.42 | 7.70 | 6.84 | 34.31 | 7.51 |
PEG Ratio | - | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.02 | 0.79 | 0.73 | 0.81 | 0.84 | 0.96 |
EV/EBITDA Ratio | 16.82 | 12.04 | 8.50 | - | 13.00 | 60.16 |
EV/EBIT Ratio | - | 29.08 | 16.39 | - | 37.55 | - |
EV/FCF Ratio | - | 7029.19 | 23.46 | 20.49 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.77 | 0.75 | 0.76 | 0.81 | 0.77 | 0.92 |
Debt / EBITDA Ratio | 6.55 | 4.94 | 3.91 | - | 6.76 | 28.44 |
Debt / FCF Ratio | - | 3331.77 | 12.10 | 8.52 | - | - |
Net Debt / Equity Ratio | 0.43 | 0.46 | 0.40 | 0.45 | 0.35 | 0.48 |
Net Debt / EBITDA Ratio | 4.06 | 3.53 | 2.28 | -7.40 | 3.12 | 14.79 |
Net Debt / FCF Ratio | -38.51 | 2060.09 | 6.30 | 4.76 | -3.09 | -16.91 |
Asset Turnover | 0.93 | 0.97 | 1.00 | 1.05 | 0.93 | 0.96 |
Inventory Turnover | 3.89 | 3.02 | 3.30 | 3.58 | 2.72 | 2.59 |
Quick Ratio | 0.53 | 0.49 | 0.62 | 0.52 | 0.78 | 0.60 |
Current Ratio | 1.31 | 1.53 | 1.52 | 1.26 | 2.00 | 1.52 |
Return on Equity (ROE) | -7.05% | 3.52% | 7.26% | -17.29% | 2.19% | -9.53% |
Return on Assets (ROA) | -1.35% | 1.65% | 2.79% | -4.45% | 1.29% | -1.73% |
Return on Invested Capital (ROIC) | -3.19% | 3.47% | 6.40% | -10.49% | 2.71% | -4.00% |
Return on Capital Employed (ROCE) | -3.10% | 4.20% | 6.90% | -13.30% | 2.90% | -4.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -5.19% | 2.09% | 6.77% | -11.39% | 2.50% | -6.10% |
FCF Yield | -0.86% | 0.02% | 5.99% | 6.27% | -9.79% | -1.91% |
Dividend Yield | 0.93% | 1.07% | 3.52% | - | 2.85% | - |
Payout Ratio | - | 210.13% | 28.65% | - | 92.90% | - |
Buyback Yield / Dilution | -4.22% | -2.12% | -1.88% | -0.95% | -21.76% | -2.13% |
Total Shareholder Return | -3.30% | -1.04% | 1.65% | -0.95% | -18.91% | -2.13% |